U.S. Breast Cancer Diagnostics Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Market Definitions
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Type and Product Snapshot
                    2.3. Application and End-use Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Trends and Outlook
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                        3.3.2. Market Restraint Analysis
                    3.4. Business Environment Analysis
                        3.4.1. PESTLE Analysis
                        3.4.2. Porter’s Five Forces Analysis
                    3.5. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
                    4.1. Breast Cancer Diagnostics Market: Type Movement Analysis, 2024 & 2033
                    4.2. Imaging
                        4.2.1. Imaging Market, 2021 - 2033 (USD Million)
                    4.3. Biopsy
                        4.3.1. Biopsy Market, 2021 - 2033 (USD Million)
                    4.4. Genomic Tests
                        4.4.1. Genomic Tests Market, 2021 - 2033 (USD Million)
                    4.5. Blood Tests
                        4.5.1. Blood Tests Market, 2021 - 2033 (USD Million)
                    4.6. Others
                        4.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Product Business Analysis
                    5.1. Breast Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2033
                    5.2. Platform-based products
                        5.2.1. Next-generation Sequencing Market, 2021 - 2033 (USD Million)
                        5.2.2. Microarrays Market, 2021 - 2033 (USD Million)
                        5.2.3. PCR Market, 2021 - 2033 (USD Million)
                        5.2.4. Others Market, 2021 - 2033 (USD Million)
                    5.3. Instrument-based products
                        5.3.1. Imaging Market, 2021 - 2033 (USD Million)
                        5.3.2. Biopsy Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
                    6.1. Breast Cancer Diagnostics Market: Application Movement Analysis, 2024 & 2033
                    6.2. Screening
                        6.2.1. Screening Market, 2021 - 2033 (USD Million)
                    6.3. Diagnostic & Predictive
                        6.3.1. Diagnostic & Predictive Market, 2021 - 2033 (USD Million)
                    6.4. Prognostic
                        6.4.1. Prognostic Market, 2021 - 2033 (USD Million)
                    6.5. Research
                        6.5.1. Research Market, 2021 - 2033 (USD Million)
Chapter 7. End-use Business Analysis
                    7.1. Breast Cancer Diagnostics Market: End-use Movement Analysis, 2024 & 2033
                    7.2. Hospitals & Clinics
                        7.2.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
                    7.3. Medical labs & Diagnostics Centers
                        7.3.1. Medical labs & Diagnostics Centers Market, 2021 - 2033 (USD Million)
                    7.4. Others
                        7.4.1. Others Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Strategy Mapping
                        8.2.1. Acquisition
                        8.2.2. Collaborations
                        8.2.3. New Platform Launches
                        8.2.4. Others
                    8.3. Company Profiles/Listing
                        8.3.1. Hologic Inc.
                            8.3.1.1. Company Overview
                            8.3.1.2. Financial Performance
                            8.3.1.3. Platform Benchmarking
                            8.3.1.4. Strategic Initiatives
                        8.3.2. Genomic Health (Exact Sciences Corporation)
                            8.3.2.1. Company Overview
                            8.3.2.2. Financial Performance
                            8.3.2.3. Platform Benchmarking
                            8.3.2.4. Strategic Initiatives
                        8.3.3. BD
                            8.3.3.1. Company Overview
                            8.3.3.2. Financial Performance
                            8.3.3.3. Platform Benchmarking
                            8.3.3.4. Strategic Initiatives
                        8.3.4. Danaher
                            8.3.4.1. Company Overview
                            8.3.4.2. Financial Performance
                            8.3.4.3. Platform Benchmarking
                            8.3.4.4. Strategic Initiatives
                        8.3.5. Koninklijke Philips N.V
                            8.3.5.1. Company Overview
                            8.3.5.2. Financial Performance
                            8.3.5.3. Platform Benchmarking
                            8.3.5.4. Strategic Initiatives
                        8.3.6. QIAGEN
                            8.3.6.1. Company Overview
                            8.3.6.2. Financial Performance
                            8.3.6.3. Platform Benchmarking
                            8.3.6.4. Strategic Initiatives
                        8.3.7. Thermo Fisher Scientific Inc
                            8.3.7.1. Company Overview
                            8.3.7.2. Financial Performance
                            8.3.7.3. Platform Benchmarking
                            8.3.7.4. Strategic Initiatives
                        8.3.8. Myriad Genetics
                            8.3.8.1. Company Overview
                            8.3.8.2. Financial Performance
                            8.3.8.3. Platform Benchmarking
                            8.3.8.4. Strategic Initiatives
                        8.3.9. Argon Medical Devices, Inc.
                            8.3.9.1. Company Overview
                            8.3.9.2. Financial Performance
                            8.3.9.3. Platform Benchmarking
                            8.3.9.4. Strategic Initiatives
                        8.3.10. F. Hoffmann-La Roche Ltd.
                            8.3.10.1. Company Overview
                            8.3.10.2. Financial Performance
                            8.3.10.3. Platform Benchmarking
                            8.3.10.4. Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 U.S. Breast Cancer Diagnostics Market, by Type, 2021 - 2033 (USD Million)
TABLE 4 U.S. Breast Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
TABLE 5 U.S. Breast Cancer Diagnostics Market by Application, 2021 - 2033 (USD Million)
TABLE 6 U.S. Breast Cancer Diagnostics Market by End-use, 2021 - 2033 (USD Million)

List of Figures

FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Market Segmentation
FIG. 8 Market Snapshot, 2024
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping, 2024
FIG. 15 U.S. Breast Cancer Diagnostics Market: Type Movement Analysis
FIG. 16 U.S. Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 17 U.S. Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 18 U.S. Genomic Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 19 U.S. Blood Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 20 U.S. Other Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 21 U.S. Breast Cancer Diagnostics Market: Product Movement Analysis
FIG. 22 U.S. Platform-Based Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 23 U.S. Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 24 U.S. Biopsy Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 25 U.S. Instrument-Based Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 26 U.S. Microarrays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 27 U.S. PCR Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 28 U.S. Next Generation Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 29 U.S. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 30 U.S. Breast Cancer Diagnostics Market: Application Movement Analysis
FIG. 31 U.S. Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 32 U.S. Diagnostic & Predictive Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 33 U.S. Prognostic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 34 U.S. Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 35 U.S. Breast Cancer Diagnostics Market: End-Use Movement Analysis
FIG. 36 U.S. Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 37 U.S. Medical Labs & Diagnostics Centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
FIG. 38 U.S. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)